Positron Corporation (POSC)
| Market Cap | 51.82M |
| Revenue (ttm) | 486.45K |
| Net Income (ttm) | -4.83M |
| Shares Out | 31.40M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500 |
| Average Volume | 6,733 |
| Open | 1.650 |
| Previous Close | 1.550 |
| Day's Range | 1.650 - 1.650 |
| 52-Week Range | 0.920 - 2.940 |
| Beta | 0.73 |
| RSI | 49.76 |
| Earnings Date | Mar 31, 2026 |
About Positron
Positron Corporation develops, manufactures, and sells cardiac positron emission tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician... [Read more]
Financial Performance
In 2024, Positron's revenue was $587,500, a decrease of -20.03% compared to the previous year's $734,666. Losses were -$2.38 million, 45.3% more than in 2023.
Financial StatementsNews
Positron Corporation Announces Its Transition to a Reporting SEC Company
Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become...
Positron Corporation Enters Industry Partnership Agreement with MedAxiom
Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging sys...
Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network's Excellence Awards 2025
Buffalo, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has won th...
Positron Corporation Announces New Corporate Headquarters and Strategic Redomiciling to Delaware
North Tonawanda, NY, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that the C...
Positron Corporation Secures Multi-Unit Sale of PET-CT Scanners to Leading Cardiology Group
Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of ...
Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner
Niagara Falls, NY, May 29, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging systems and services, is pleased to announce the sale ...
Positron Corporation Secures Agreement to Sell Four PET-CT Scanners
Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT ...
Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion
Niagara Falls, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography ...
Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners
Niagara Falls, NY, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT imaging systems and clinical su...
Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners
Niagara Falls, NY, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT (...
Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners
Niagara Falls, NY, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT i...
Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO
CHALK RIVER, Ontario--(BUSINESS WIRE)--Actineer, a joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., today announced the appointment of Joseph Oliverio as President and Chief Exe...
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
Niagara Falls, NY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Partners With Upbeat Cardiology Solutions to Expand Cardiac PET-CT Offerings
Niagara Falls, NY, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Launches Prime Rental Program for Pet-Ct Systems
Niagara Falls, NY, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Announces Sale of NeuSight PET-CT Scanner
Niagara Falls, NY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT
Niagara Falls, NY, July 25, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET & PET-CT imaging sy...
Positron Corporation Orders 5 NeuSight PET-CT Scanners for US Market
Niagara Falls, NY, June 26, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Announces Attrius® PET System Sale
Niagara Falls, NY, June 18, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)
Niagara Falls, NY, June 14, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters OEM Supply and Distribution Agreement for NeuSight PET-CT 64 Slice Scanner
Niagara Falls, NY, June 13, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters Agreement to Acquire FDA 510(k) for NeuSight PET-CT
Niagara Falls, NY, June 12, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positro...
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device
Niagara Falls, NY, July 21, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company, is pleased to announce that the...
Positron Corporation Enters into Agreement with Ochsner Clinic Foundation for Clinical Study of its New “Affinity PET-CT 4D” Device
Niagara Falls, NY, March 01, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a molecular imaging device company that offers PET imaging systems and clinical se...
Positron Corporation Announces Plans for Clinical Study of its New “Affinity PET-CT 4D” Nuclear Imaging Device
Niagara Falls, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a nuclear medicine PET imaging systems and clinical services company, is pleased to...